Lifshitz Law PLLC Announces Investigations of Innodata Inc. (NASDAQ:INOD), Agilon Health, Inc. (NYSE:AGL), Cassava Sciences, Inc. (NASDAQ: SAVA), and The Boeing Company (NYSE: BA)

12:03 AM EDT 4/20/2024 - Comtex

Apr 20, 2024 (ACCESSWIRE via COMTEX News Network) -- NEW YORK, NY / April 19, 2024 / ACCESSWIRE / Lifshitz Law PLLC:

Innodata Inc. (NASDAQ:INOD)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company did not have a viable AI technology; (ii) its Goldengate AI platform is a rudimentary software developed by just a handful of employees; (iii) it was not going to utilize AI to any significant degree for new Silicon Valley contracts; (iv) it was not effectively investing in research and development for AI; and (v) based on the foregoing, the Company lacked a reasonable basis for its positive statements about Innodata's AI business and development and related financial results, growth, and prospects.

If you are an INOD investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Agilon Health, Inc. (NYSE:AGL)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company misled investors about the Company's medical costs by: (i) touting the Company's purported visibility into utilization trends and medical costs; (ii) failing to disclose increased medical costs that the Company had incurred due to higher utilization of healthcare by Medicare Advantage patients; (iii) falsely stating that its IBNR Reserve was adequate; (iv) making false and misleading statements about the effectiveness of its business model; (v) issuing overly optimistic financial guidance; and (vi) issuing risk disclosures that were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities.

If you are an AGL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Cassava Sciences, Inc. (NASDAQ:SAVA)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company failed to maintain adequate and effective data management controls and procedures related to its drug research programs; (ii) the data published in support of simufilam were susceptible to manipulation to overstate the drug's effectiveness; (iii) accordingly, Cassava Sciences had misrepresented the efficacy of its research programs and the clinical and/or commercial prospects of simufilam; (iv) all of the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are a SAVA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

The Boeing Company (NYSE:BA)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) throughout the Relevant Period, the Company made false and misleading statements about the its safety and quality efforts; (ii) Boeing failed to disclose that it had been prioritizing its profits over safety, which led to poor quality control standards in the production of its commercial aircraft such as the 737 MAX, resulting in a heightened risk of manufacturing flaws which could render the Company's new airplanes unsafe; and (iii) as a result of the foregoing, Boeing stock traded at artificially inflated prices during the Relevant Period.

If you are a BA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING. 2024 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.Lifshitz Law PLLC Phone: 516-493-9780Facsimile: 516-280-7376Email: info@lifshitzlaw.com

SOURCE: Lifshitz Law PLLC

COMTEX_451115003/2457/2024-04-20T00:03:19